NLS Collaboration

The Gates Foundation, Novo Nordisk Foundation, and Wellcome has awarded a new grant funding over the next three years to research teams around the world exploring novel approaches to antibiotic discovery to deal with the growing threat of antimicrobial resistance (AMR).

As global tensions rise and the United States moves in a more unpredictable direction, Europe’s life science sector is under pressure to strengthen its competitiveness. According to Medicon Valley Alliance's (MVA) CEO, Anette Steenberg, the Nordics have a decisive role to play – but only if the region can act as one.

Women in Life Science Denmark (WiLD) has announced the launch of WiLD Finland.

The two companies are entering a new phase of their partnership to develop advanced cellular medicines for diabetes.

Lithuanian company Biomatter is an enzyme design company that bridges the gap between generative AI and real-world industrial applications.

AAX Biotech will leverage its Seqitope platform and automation infrastructure to accelerate antibody characterization, driving faster, data-driven insights across drug discovery and development.